Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 212

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 212
---
 $1.9 million increase in payments (net of sales proceeds) for the purchase of property, plant and equipment and internally generated intangible assets in the nine months ended September 30, 2025 compared to  the nine months ended September 30, 2024. This increase in net cash used was partially offset by proceeds of $23.4 million from the maturity of term deposits in the nine months ended September 30, 2025, compared to no proceeds from investments in the nine months ended September 30, 2024.  

Cash flows used for/provided by financing activities. Our net cash used for financing activities was $315.6 million in the nine months ended September 30, 2025 compared to net cash provided by financing activities of $92.6 million in the nine months ended September 30, 2024. This change was primarily due to (i) higher repayments of borrowings (net of proceeds), amounting to $19.9 million in the nine months ended September 30, 2025 compared to proceeds from borrowings (net of repayments and debt issuance and refinancing costs) of $359.4 million in the nine months ended September 30, 2024, (ii) higher payments for stock repurchased and retired (including related expenses), amounting to $183.0 million in the nine months ended September 30, 2025 compared to $167.7 million in the nine months ended September 30, 2024, (iii) higher payments for the net settlement of stock-based awards, amounting to $31.8 million in the nine months ended September 30, 2025 compared to $21.3 million in the nine months ended September 30, 2024, and (iv) higher dividend payments of $88.7 million in the nine months ended September 30, 2025 compared to $81.8 million in the nine months ended September 30, 2024.

64

Financing Arrangements

In December 2022, we entered into an amended and restated credit agreement (the "2022 Credit Agreement") with Genpact USA, Inc. (“Genpact USA”), Genpact Global Holdings (Bermuda) Limited (“GGH”) and Genpact Luxembourg S.à r.l. (“Genpact Luxembourg”, and together with Genpact USA and GGH, the “Borrowers”), as borrowers, Wells Fargo Bank, National Association